These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21037190)

  • 1. Chronic kidney disease: pharmacological considerations for the dentist.
    Brockmann W; Badr M
    J Am Dent Assoc; 2010 Nov; 141(11):1330-9. PubMed ID: 21037190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular drugs: implications for dental practice. Part 2--antihyperlipidemics and antithrombotics.
    Becker DE
    Anesth Prog; 2008; 55(2):49-55; quiz 56-7. PubMed ID: 18547153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in children with chronic kidney disease.
    Schijvens AM; de Wildt SN; Schreuder MF
    Pediatr Nephrol; 2020 Jul; 35(7):1153-1172. PubMed ID: 31375913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
    Farag A; Garg AX; Li L; Jain AK
    Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dosing adjustment and renal function: Which equation(s)?].
    Delanaye P; Flamant M; Cavalier É; Guerber F; Vallotton T; Moranne O; Pottel H; Boffa JJ; Mariat C
    Nephrol Ther; 2016 Feb; 12(1):18-31. PubMed ID: 26602880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ; Steffl JL
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe Use of Metformin in Adults With Type 2 Diabetes and Chronic Kidney Disease: Lower Dosages and Sick-Day Education Are Essential.
    MacCallum L; Senior PA
    Can J Diabetes; 2019 Feb; 43(1):76-80. PubMed ID: 30061044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ; Urquhart BL
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
    Weir MR; Fink JC
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):306-13. PubMed ID: 24670404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.
    Chapron A; Shen DD; Kestenbaum BR; Robinson-Cohen C; Himmelfarb J; Yeung CK
    Clin Transl Sci; 2017 Sep; 10(5):395-403. PubMed ID: 28675584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
    Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
    MacCallum L
    Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.
    Parsh J; Seth M; Aronow H; Dixon S; Heung M; Mehran R; Gurm HS
    J Am Coll Cardiol; 2015 Jun; 65(25):2714-23. PubMed ID: 26112195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.
    Tortorici MA; Cutler DL; Hazra A; Nolin TD; Rowland-Yeo K; Venkatakrishnan K
    J Clin Pharmacol; 2015 Mar; 55(3):241-50. PubMed ID: 25501531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.
    Delanaye P; Guerber F; Scheen A; Ellam T; Bouquegneau A; Guergour D; Mariat C; Pottel H
    Clin Pharmacokinet; 2017 Feb; 56(2):193-205. PubMed ID: 27417226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs in renal disease and pregnancy.
    Sarwar A
    Best Pract Res Clin Obstet Gynaecol; 2019 May; 57():106-119. PubMed ID: 31031053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective Analysis.
    Saleem A; Masood I
    PLoS One; 2016; 11(7):e0158677. PubMed ID: 27367594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.